Hematology/Oncology — Medicare Part B billing by state
188 physician groups whose primary specialty is Hematology/Oncology billed $1.38B to Medicare fee-for-service in 2023.
Calendar year 2023 · Medicare fee-for-service Part B
You're viewing calendar year 2023. State market links open the latest data year.
| State | Groups | Services | Beneficiary-episodes | Medicare payments | Standardized payments ↓ | Payments / group | Services / group |
|---|---|---|---|---|---|---|---|
| Florida | 20 | 33,793,201 | 1,794,699 | $363,342,283 | $365,227,737 | $18,167,114 | 1,689,660 |
| California | 34 | 11,407,135 | 415,450 | $149,581,240 | $144,470,089 | $4,399,448 | 335,504 |
| Arkansas | 3 | 5,630,658 | 280,254 | $71,376,658 | $73,547,852 | $23,792,219 | 1,876,886 |
| Maryland | 8 | 6,444,874 | 184,078 | $73,158,425 | $72,226,049 | $9,144,803 | 805,609 |
| New Jersey | 12 | 5,029,301 | 206,201 | $70,413,157 | $67,967,108 | $5,867,763 | 419,108 |
| Virginia | 10 | 4,096,632 | 164,107 | $63,495,522 | $63,194,663 | $6,349,552 | 409,663 |
| Illinois | 18 | 5,557,875 | 187,423 | $59,521,861 | $59,631,463 | $3,306,770 | 308,771 |
| Tennessee | 6 | 5,399,606 | 246,800 | $57,564,381 | $59,580,021 | $9,594,063 | 899,934 |
| Kansas | 1 | 3,862,648 | 88,394 | $53,589,852 | $54,163,769 | $53,589,852 | 3,862,648 |
| Pennsylvania | 16 | 3,743,716 | 128,144 | $44,401,023 | $44,269,025 | $2,775,064 | 233,982 |
| Arizona | 6 | 3,150,534 | 104,152 | $42,725,987 | $43,427,096 | $7,120,998 | 525,089 |
| Texas | 16 | 3,120,609 | 106,324 | $37,124,184 | $37,858,795 | $2,320,262 | 195,038 |
| South Carolina | 5 | 2,663,301 | 103,578 | $34,673,644 | $35,683,666 | $6,934,729 | 532,660 |
| Mississippi | 4 | 2,093,817 | 63,985 | $29,467,014 | $30,910,994 | $7,366,753 | 523,454 |
| North Carolina | 9 | 1,724,653 | 93,084 | $28,750,397 | $29,347,309 | $3,194,489 | 191,628 |
| Georgia | 9 | 2,364,862 | 106,388 | $27,177,579 | $27,731,915 | $3,019,731 | 262,762 |
| Indiana | 5 | 1,435,312 | 64,705 | $19,439,681 | $19,838,799 | $3,887,936 | 287,062 |
| Delaware | 1 | 775,490 | 17,855 | $18,473,008 | $18,486,598 | $18,473,008 | 775,490 |
| Ohio | 13 | 1,765,000 | 64,766 | $17,934,799 | $18,293,924 | $1,379,600 | 135,769 |
| Nevada | 5 | 893,042 | 39,440 | $16,997,123 | $17,123,105 | $3,399,425 | 178,608 |
| Maine | 2 | 944,531 | 30,507 | $14,005,028 | $14,091,474 | $7,002,514 | 472,266 |
| Louisiana | 5 | 658,287 | 31,982 | $11,337,539 | $11,782,477 | $2,267,508 | 131,657 |
| Washington | 5 | 1,103,447 | 45,508 | $11,600,871 | $11,610,392 | $2,320,174 | 220,689 |
| Michigan | 8 | 945,909 | 51,314 | $10,523,093 | $10,686,366 | $1,315,387 | 118,239 |
| Missouri | 10 | 219,709 | 32,832 | $6,627,484 | $6,738,162 | $662,748 | 21,971 |
| New York | 10 | 785,792 | 39,222 | $6,537,011 | $5,963,493 | $653,701 | 78,579 |
| New Mexico | 3 | 373,941 | 42,320 | $5,345,093 | $5,469,726 | $1,781,698 | 124,647 |
| Nebraska | 1 | 421,659 | 6,661 | $5,159,756 | $5,242,083 | $5,159,756 | 421,659 |
| Alabama | 2 | 142,536 | 3,712 | $4,115,657 | $4,264,937 | $2,057,828 | 71,268 |
| Alaska | 2 | 162,459 | 7,148 | $4,003,325 | $3,861,058 | $2,001,663 | 81,230 |
| Massachusetts | 5 | 283,494 | 9,887 | $3,868,263 | $3,822,506 | $773,653 | 56,699 |
| Connecticut | 5 | 282,104 | 12,472 | $3,645,062 | $3,525,552 | $729,012 | 56,421 |
| Vermont | 2 | 164,511 | 6,532 | $3,476,742 | $3,440,850 | $1,738,371 | 82,256 |
| Oregon | 4 | 228,770 | 4,659 | $2,323,254 | $2,328,730 | $580,813 | 57,192 |
| Iowa | 2 | 156,648 | 4,849 | $2,080,136 | $2,104,909 | $1,040,068 | 78,324 |
| XX | 1 | 80,845 | 3,877 | $1,447,511 | $1,460,632 | $1,447,511 | 80,845 |
| PR | 8 | 58,159 | 5,404 | $1,368,635 | $1,379,532 | $171,079 | 7,270 |
| South Dakota | 1 | 30,266 | 1,397 | $1,060,999 | $1,060,623 | $1,060,999 | 30,266 |
| New Hampshire | 2 | 104,911 | 1,919 | $966,761 | $956,928 | $483,381 | 52,456 |
| Minnesota | 2 | 49,425 | 2,160 | $583,029 | $587,204 | $291,515 | 24,712 |
| Wisconsin | 4 | 11,979 | 3,184 | $470,866 | $489,021 | $117,717 | 2,995 |
| Oklahoma | 3 | 9,111 | 5,477 | $415,024 | $438,951 | $138,341 | 3,037 |
| Kentucky | 2 | 25,482 | 1,346 | $203,621 | $220,417 | $101,811 | 12,741 |
| VI | 1 | 1,440 | 577 | $98,723 | $99,542 | $98,723 | 1,440 |
| District of Columbia | 3 | 1,247 | 613 | $97,002 | $90,982 | $32,334 | 416 |
| Utah | 1 | 545 | 194 | $59,244 | $59,836 | $59,244 | 545 |
| Colorado | 1 | 173 | 124 | $12,671 | $13,768 | $12,671 | 173 |
Need this specialty's market in one document?
Notify me at launchEach group carries one specialty label — the specialty most common among its clinicians in CMS's Doctors and Clinicians register — so every figure on this page counts groups, not individual clinicians. An organization's entire Medicare billing is credited to that one label, so a specialty's totals reflect how organizations are labeled, not the specialty of each service; large multi-specialty organizations — where no single specialty is a majority of the clinicians — account for much of the volume shown under many specialties. Totals include only volume that can be credited to a single group; clinicians registered with more than one group are left out of group totals and shown as “—” elsewhere on Nevvi. Clinicians not registered with any group, and groups without a specialty label, are also not included. A group is counted in every state its clinicians bill Medicare from, so state figures overlap and never sum to the national figure.
All figures are Medicare fee-for-service Part B only; Medicare Advantage claims are not included. Cross-state comparisons use standardized payments, which remove regional differences in what Medicare pays; services without a standardized amount — mainly Part B drugs — are not in that column, and the Medicare payments column shows what Medicare actually paid. Beneficiary counts are beneficiary-episodes: one person treated in more than one setting or state is counted in each.
Top codes by Medicare payments CY2023
| Code | Services | Medicare payments ↓ | Largest state markets |
|---|---|---|---|
| J9271 · Injection, pembrolizumab, 1 mg | 8,771,217 | $376,196,156 | FLCAARMDNJ |
| J0897 · Injection, denosumab, 1 mg | 6,310,143 | $115,301,084 | FLCAARMDNJ |
| 99214 · Established patient office or other outpatient visit, 30-39 minutes | 965,922 | $89,201,746 | FLCAARMDNJ |
| J9299 · Injection, nivolumab, 1 mg | 3,341,281 | $78,510,736 | FLCAARMDNJ |
| J9144 · Injection, daratumumab, 10 mg and hyaluronidase-fihj | 1,833,840 | $69,071,741 | FLCAARMDNJ |
| 96413 · Administration of chemotherapy into vein, 1 hour or less | 369,522 | $37,418,564 | FLCAARMDNJ |
| 99213 · Established patient office or other outpatient visit, 20-29 minutes | 507,484 | $32,498,062 | FLCAARMDNJ |
| 78815 · Nuclear medicine study from skull base to mid-thigh with ct scan | 27,129 | $32,076,787 | FLCAARMDNJ |
| 99215 · Established patient office or other outpatient visit, 40-54 minutes | 237,576 | $31,328,302 | FLCAARMDNJ |
| J1569 · Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 771,124 | $27,501,791 | FLCAARMDNJ |
| J1439 · Injection, ferric carboxymaltose, 1 mg top by services | 18,707,475 | $16,280,438 | FLCAARMDNJ |
| J0881 · Injection, darbepoetin alfa, 1 microgram (non-esrd use) top by services | 6,818,680 | $15,954,833 | FLCAARMDNJ |
| J0185 · Injection, aprepitant, 1 mg top by services | 4,199,097 | $5,726,178 | FLCAARMDNJ |
| Q0138 · Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) top by services | 13,585,834 | $5,355,024 | FLCAARMDNJ |
| J1756 · Injection, iron sucrose, 1 mg top by services | 3,785,811 | $606,327 | FLCAARMDNJ |
| Q5101 · Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram top by services | 2,707,094 | $433,273 | FLCAARMDNJ |
| Q9967 · Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml top by services | 3,151,208 | $360,518 | FLCAARMDNJ |
Every code above is searchable free at full depth. Ranking organizations across several codes at once — one combined market view — is part of a Nevvi subscription.
Notify me at launch